Key result
Targeted ablation of Bnip3 reduced periinfarct cardiomyocyte apoptosis from 11.5% to 6.7% and prevented late ventricular remodeling after ischemia/reperfusion injury in mice.
Why the study?
Does targeted ablation of Bnip3 prevent ventricular remodeling and cardiomyocyte apoptosis in mice following ischemia/reperfusion injury?
Does targeted ablation of Bnip3 prevent ventricular remodeling and cardiomyocyte apoptosis in mice following ischemia/reperfusion injury?
Targeted ablation of the proapoptotic gene Bnip3 reduces post-ischemic cardiomyocyte apoptosis and prevents adverse ventricular remodeling in mice, identifying it as a potential therapeutic target for post-MI heart failure.
Answers are grounded in this paper and cite their sources.
Caution against clinical use in MI; extends causal RCT evidence for Bnip3 inhibition in mouse post-IR remodeling.
Following myocardial infarction, nonischemic myocyte death results in infarct expansion, myocardial loss, and ventricular dysfunction. Here, we demonstrate that a specific proapoptotic gene, Bnip3, minimizes ventricular remodeling in the mouse, despite having no effect on early or late infarct size. We evaluated the effects of ablating Bnip3 on cardiomyocyte death, infarct size, and ventricular remodeling after surgical ischemia/reperfusion (IR) injury in mice. Immediately following IR, no significant differences were observed between Bnip3(-/-) and WT mice. However, at 2 days after IR, apoptosis was diminished in Bnip3(-/-) periinfarct and remote myocardium, and at 3 weeks after IR, Bnip3(-/-) mice exhibited preserved LV systolic performance, diminished LV dilation, and decreased ventricular sphericalization. These results suggest myocardial salvage by inhibition of apoptosis. Forced cardiac expression of Bnip3 increased cardiomyocyte apoptosis in unstressed mice, causing progressive LV dilation and diminished systolic function. Conditional Bnip3 overexpression prior to coronary ligation increased apoptosis and infarct size. These studies identify postischemic apoptosis by myocardial Bnip3 as a major determinant of ventricular remodeling in the infarcted heart, suggesting that Bnip3 may be an attractive therapeutic target.
No takes yet. Share an insight, caveat, or question.
Diwan et al. (2007) studied Myocardial infarction (ischemia/reperfusion injury). Bnip3 gene ablation vs. Wild-type (WT) mice was evaluated on Apoptosis rate in the periinfarct region at 48 hours after ischemia/reperfusion (p=0.011). Targeted ablation of Bnip3 reduced periinfarct cardiomyocyte apoptosis from 11.5% to 6.7% and prevented late ventricular remodeling after ischemia/reperfusion injury in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: